Medicare Advantage coverage restrictions for the costliest physician-administered drugs.
Am J Manag Care
; 28(7): e255-e262, 2022 07 01.
Article
in En
| MEDLINE
| ID: mdl-35852888
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Physicians
/
Medicare Part C
/
Medicare Part D
Type of study:
Observational_studies
Limits:
Aged
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Am J Manag Care
Journal subject:
SERVICOS DE SAUDE
Year:
2022
Document type:
Article
Country of publication:
United States